+44 (0) 1698 534002
Contact

News

Presentation: Innovative Assays for Hit Confirmation

19 March 2021

In this short presentation, Dr Phil Jones, Chief Scientific Officer at BioAscent, discusses an innovative assay that was...

Read more

BioAscent tops outsourcing category in the Alantra Pharma Fast 50

01 March 2021

BioAscent has topped the outsourcing category in the Alantra Pharma Fast 50 for the second year running. The annual repo...

Read more

Fast 50 Voices

20 January 2021

Ahead of the launch of the 2021 Alantra Pharma Fast 50, Tom Cowap, Director of Healthcare at Alantra, spoke to Paul Smit...

Read more

BioAscent reports significant growth in discovery business services

13 January 2021

BioAscent has continued its stellar growth throughout the past year.  This growth has been driven by its drug discovery ...

Read more

Case study: Supporting the compound management value proposition

05 November 2020

BioAscent has a long-standing relationship with Titian Software, and in a recent case study put together by the team at...

Read more

Drug Discovery World: Dr Phil Jones discusses why quality leads matter

13 October 2020

In the latest issue of Drug Discovery World magazine, BioAscent's Chief Scientific Officer, Dr Phil Jones, outlines...

Read more

BioAscent invests £1m to expand drug discovery service offering

03 September 2020

BioAscent has further enhanced its comprehensive service offering in integrated drug discovery and compound management,...

Read more

BioAscent invests in FLIPR Penta High-Throughput Cellular Screening System

16 July 2020

BioAscent has invested in a FLIPR Penta screening system, enhancing its high-throughput cellular screening capabilities...

Read more

Compound Management – what our customers say

10 July 2020

BioAscent’s compound management service offers customers secure compound aggregation and storage, up-to-date visibility...

Read more

BioAscent appoints Nick Moore, PhD to steer growth in US

23 June 2020

To support its ongoing growth in the US, BioAscent has appointed Nick Moore, PhD to head up business development in Nort...

Read more

Integrated Drug Discovery

Science-led drug discovery

Compound Management

Connecting and accelerating your drug discovery

Medicinal Chemistry

Proven expertise in design and synthesis

In Silico Discovery

Accelerating drug design with computational expertise

Discovery Biology

Screening expertise across target classes

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact